Greer v. Hawaii Permanente Medical Group, Inc.

CourtDistrict Court, D. Hawaii
DecidedJanuary 31, 2025
Docket1:24-cv-00299
StatusUnknown

This text of Greer v. Hawaii Permanente Medical Group, Inc. (Greer v. Hawaii Permanente Medical Group, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Hawaii primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Greer v. Hawaii Permanente Medical Group, Inc., (D. Haw. 2025).

Opinion

IN THE UNITED STATES DISTRICT COURT

FOR THE DISTRICT OF HAWAII

DONALD S. GREER, CIV. NO. 24-00299 JMS-RT

Plaintiff, ORDER GRANTING DEFENDANTS’ MOTIONS TO v. DISMISS, ECF NOS. 18, 22, 25, AND 30 HAWAII PERMANENTE MEDICAL GROUP, INC.; HAWAII PACIFIC HEALTH; THE QUEEN’S HEALTH SYSTEM; HAWAII HEALTH SYSTEMS CORPORATION,

Defendants.

ORDER GRANTING DEFENDANTS’ MOTIONS TO DISMISS, ECF NOS. 18, 22, 25, AND 30

I. INTRODUCTION On July 16, 2024, pro se Plaintiff Donald S. Greer (“Plaintiff” or “Greer”) filed a Complaint against Defendants Hawaii Health System Corporation (“HHSC”), Hawaii Permanente Medical Group, Inc. (“HPMG”), The Queen’s Health System (“QHS”), and Hawaii Pacific Health (“HPH”) alleging: Count I— violations of Title III of the Americans with Disabilities Act, 42 U.S.C. § 12182 (“ADA”) (against Defendants HPMG, QHS, and HPH only); Count II—violations of Section 504 of the Rehabilitation Act, 29 U.S.C. § 794(a) (“Rehabilitation Act”); Count III—violations of Section 1557 of the Patient Protection and Affordable Care Act, 42 U.S.C. § 18116 (“ACA”); and Count IV—violations of Hawaii Law Against Discrimination in Public Accommodations, Hawaii Revised Statutes

(“HRS”) § 489-1, et seq. for purported concealment, denial, and withholding of medical treatment. Before the court are Defendants’ Motions to Dismiss for failure to state a claim. ECF Nos. 18, 22, 25, & 30 (“Motion” or “Motions”). For the

following reasons, Defendants’ Motions are GRANTED. II. BACKGROUND A. Factual Background On July 16, 2024, Plaintiff filed his 557-paragraph and 113-page

Complaint. Given this length, the court does not set forth all its allegations but instead gleans the following: Seventy-one-year-old Plaintiff alleges that for 58 years he has received discriminatory treatment by numerous physicians.1 See ECF No. 1 at PageID.7

(¶ 9); see also PageID.73 (¶ 401.m.). In 1957, when he was four, Plaintiff contracted polio, resulting in the loss of approximately one-third to one-half of his motor nerves and partial paralysis. See id. at PageID.6 (¶ 5); id. at PageID.12

(¶ 32); id. at PageID.13 (¶ 34); id. at PageID.14 (¶ 39). In 1966, when he was 13, id. at PageID.14 (¶¶ 42, 44), Plaintiff developed an atrophic left testicle and

1 Plaintiff characterizes them as “Defendant Physicians” although none of them is named individually in this action. testicular pain, which “Kaiser Permanente Physicians in California [(‘California KP’)] falsely diagnosed” as a “[t]esticular [d]isability” “caused by nerve damage

from Polio and untreatable with the exception of removal.” Id. at PageID.7 (¶¶ 7, 8), PageID.15 (¶ 46). California KP allegedly conducted no medical tests to rule out a varicocele.2 Id. at PageID.16 (¶ 53). Instead, California KP allegedly

exploited Greer’s polio disability to “conceal and withhold Testicular Disability medical treatment,” id. (¶ 57), and “brainwashed” Plaintiff into believing that the cause of his testicular condition was polio. Id. at PageID.17 (¶ 58). Plaintiff’s California KP medical records have been discarded due to age. Id. (¶ 59).

In 2002, Plaintiff moved to Kauai County, Hawaii. Id. at PageID.10 (¶ 19), PageID.18 (¶ 66). He sought treatment with numerous physicians of HHSC, HPH, and QHS, many of whom he informed of his history of “Polio Disability” and

“Testicular Disability,” but he alleges that they omitted this information from his medical records prior to November 27, 2018—when he was diagnosed with having a varicocele—or otherwise falsified them. See id. at PageID.32 (¶ 150); see also id. at PageID.75 (¶ 410); PageID.83 (¶ 453.h.). Assuming the truth of the Complaint’s

allegations at the motion-to-dismiss stage, the following timeline extracted from the

2 A varicocele is a common medical condition characterized by abnormal dilation and enlargement of the scrotal venous pampiniform plexus, which drains blood from each testicle. The result is often a complex network of swollen vessels. See Varicocele, National Center for Biotechnology Information, https://www.ncbi.nlm.nih.gov/books/NBK448113/ [https://perma.cc/ 7XEK-ZG3B]. Complaint shows that Plaintiff consulted with numerous physicians to address his conditions, which includes treatment for an adverse reaction to tamsulosin, a drug

allegedly prescribed to “prevent testicular recovery”:3 Dr. O’Neill 2009–2013 Primary care physician (Defendant HHSC), id. at PageID.20 (¶ 80)

Dr. Scott 2009 Performs colonoscopy (Defendant HHSC), PageID.22 (¶ 99)

Dr. Rao 2012 Neurologist (Defendant HPH), id. at PageID.25 (¶ 114)

Dr. Dupree 2013–2022 Primary care physician (Defendant HHSC), id. at PageID.20 (¶ 84)

Dr. Miyashiro 2013 Surgeon (Defendant HPH), id. at PageID.25 (¶ 114)

Dr. Hopkins 2013–2018 Physical medicine (Defendant HPH), id.

Dr. Fitzgerald 2018–2019 Urologist (Defendant HPH), id. at PageID.22 (¶ 93); diagnoses Plaintiff’s varicocele and informs him that his testicular condition is not due to polio, id. at PageID.7 (¶ 8); id. at PageID.22 (¶¶ 94–96)

3 See ECF No. 1 at PageID.33 (“HPH Defendant Prescribing a Drug, Tamsulosin, to Prevent Testicular Recovery.”). Tamsulosin is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (“BPH”). See Tamsulosin hydrochloride capsule, Indications & Usage, National Library of Medicine, https://dailymed.nlm.nih.gov/dailymed/ drugInfo.cfm?setid=ed9988bc-0759-4c36-bee1-11b68dc1c84c [https://perma.cc/BN5C-7HLH]. BPH, in turn, refers to the nonmalignant growth or hyperplasia of prostate tissue and is a common cause of lower urinary tract symptoms in older men. See Benign Prostatic Hyperplasia, National Library of Medicine, https://www.ncbi.nlm.nih.gov/books/NBK558920/ [https://perma.cc/ VW9G-KE69]. 2019 Schedules varicocele surgery, id. at PageID.7 (¶ 9); prescribes tamsulosin, id. at PageID.33 (¶ 157), Plaintiff has adverse reaction, id. at PageID.53 (¶ 275)4

Dr. Morris Dr. Phillips 2019 Performs colonoscopy (Defendant HPH), id. at PageID.25 (¶ 111)

Dr. Jackson 2019 Performs sleep study (Defendant HPH), id. at PageID.43 (¶ 207)

Dr. Leckova 2016, 2019 Hematologist and oncologist (Defendant HPH), id. at PageID.25 (¶ 114)

Dr. So 2019, 2021 Cardiologist (Defendant HPH), id. at PageID.46–47 (¶¶ 232, 233)

Dr. Chin 2020 Neurologist (Defendant QHS), id. at PageID.23 (¶ 105)

Dr. Sato 2021 Pulmonologist (Defendant QHS), id. at PageID.24 (¶ 108)

Dr. Lui 2022 Primary care physician (Defendant HHSC), id. at PageID.43 (¶ 209) Dr. Kai 2022, 2023 Cardiologist (Defendant HPH), id. at PageID.25 (¶ 114)

4 Plaintiff alleges a testicular ultrasound performed on January 11, 2019, prior to taking tamsulosin, showed a normal right testicle and an atrophic left testicle, a left varicocele and a possible right varicocele. ECF No. 1 at PageID.38 (¶¶ 183, 184). A second testicular ultrasound was performed on May 2, 2019, after Plaintiff began taking tamsulosin. Id. (¶ 185). This ultrasound showed that Plaintiff’s right testicle shrunk by 23%, no atrophic left testicle, no left varicocele and no right varicocele. Id. (¶ 186). Plaintiff alleges that on May 16, 2019, two weeks after the second ultrasound, Dr. Fitzgerald “medically abandoned” him. Id. at PageID.39 (¶ 191). Plaintiff emailed Dr. Fitzgerald for help and an explanation but received no response and no further treatment from Dr. Fitzgerald. Id. (¶ 192). Thus, it appears that Plaintiff did not undergo varicocele surgery and no other doctor ordered it. See, e.g., id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Conley v. Gibson
355 U.S. 41 (Supreme Court, 1957)
City of Los Angeles v. Lyons
461 U.S. 95 (Supreme Court, 1983)
Carnegie-Mellon University v. Cohill
484 U.S. 343 (Supreme Court, 1988)
Jones v. R. R. Donnelley & Sons Co.
541 U.S. 369 (Supreme Court, 2004)
Erickson v. Pardus
551 U.S. 89 (Supreme Court, 2007)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Simmons v. Navajo County, Ariz.
609 F.3d 1011 (Ninth Circuit, 2010)
Hebbe v. Pliler
627 F.3d 338 (Ninth Circuit, 2010)
Fitzgerald v. Corrections Corp. of America
403 F.3d 1134 (Tenth Circuit, 2005)
Edward G. Eldridge v. Sherman Block
832 F.2d 1132 (Ninth Circuit, 1987)
Johnson v. Thompson
971 F.2d 1487 (Tenth Circuit, 1992)
Skilstaf, Inc. v. Cvs Caremark Corp.
669 F.3d 1005 (Ninth Circuit, 2012)
Roy O'Guinn v. Nevada Department of Correction
468 F. App'x 651 (Ninth Circuit, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
Greer v. Hawaii Permanente Medical Group, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/greer-v-hawaii-permanente-medical-group-inc-hid-2025.